Texas Judge Approves CVS’s Omnicare Bankruptcy Plan, Set to Wind Down Division

A Texas bankruptcy judge approved a plan last week to wind down CVS Health’s long-term care pharmacy unit, Omnicare, after the sale of its business and resolution of major legal liabilities. This chapter in CVS’s restructuring takes effect in October.

The U.S. Bankruptcy Court for the Northern District of Texas granted approval on September 17, 2026, for a plan to reorganize and liquidate Omnicare’s assets following its sale for $250 million and settlement of an approximately $1 billion judgment tied to improper billing to government healthcare programs. The plan ensures full repayment to all creditors. The wind-down is scheduled to begin in October.

Omnicare, which filed for Chapter 11 bankruptcy in September 2025, had faced a $949 million judgment for allegedly dispensing prescription drugs without valid prescriptions and billing Medicaid and Medicare improperly. The plan calls for a structured distribution of proceeds and creditor payments and is backed by the Department of Justice under a deal that includes an upfront $130 million payment and a guarantee by CVS to cover the remaining $310 million if needed by March 2028.

This development is a notable milestone in CVS’s legal and financial clean-up, marking finality in a high-profile litigation saga. While comprehensive financial outcomes for CVS’s consolidated reporting remain to be published in upcoming earnings or filings, the approval paves the way for clarity on legacy liabilities tied to the Omnicare division.

Investors should anticipate further detail when CVS Health reports its next earnings or issues updated financial disclosures. The resolution of the Omnicare matter removes a long-dated uncertainty and positions CVS to better focus on its core health services operations.

Timeline at a glance:

• September 22, 2025: Omnicare filed for Chapter 11 bankruptcy.
• May 2026: Sale of Omnicare’s business operations approved.
• July 2026: CVS and Omnicare reached a settlement with the DOJ outlining payment structure.
• September 17, 2026: Bankruptcy court approved the wind-down plan.
• October 2026: Plan is set to go into effect.

This outcome should be viewed as a near-term de-risking event for CVS, even as the company continues executing on strategic priorities in pharmacy, health benefits, and care delivery.